Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06341894
Status:
RECRUITING
Last Update Posted:
2024-04-02
First Post:
2024-02-24
Brief Title:
Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR HER2- Early Breast Cancer
Sponsor:
Organization:
The First Affiliated Hospital with Nanjing Medical University